Want to join the conversation?
In 1Q16, for $LH's LabCorp Diagnostics segment, revenue was $1.6Bil, an increase of 7.2% over last year. The increase in revenue was the result of organic volume growth, Beacon LBS, price, mix and tuck-in acquisitions, partially offset by currency. For Covance Drug Development, revenue was $703MM, an increase of 12.6% over last year.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.